Serum-Mediane von Placentaprotein-Markern: Relevanz der Unterschiede zwischen spontanen und nach-in-vitro-Fertilisation eingetretenen Schwangerschaften für das fetale Trisomie-Screening.

Trisomy-21 (Down syndrome) is the most frequent chromosomal abnorm- ality but only one third of cases would be detected by amniocentesis based on maternal age alone. Serum screening tests in the early second trimester increase the detec- tion rate to 60-65%, and more recently it was found that such screening was also possible in the first trimester by quantifying a diffe- rent panel of markers. The concen- trations of these placental proteins are strongly dependent on gestatio- nal age; thus control medians must be established and precise dating is essential. Serum chorionic gonado- trophin (HCG) levels were recently found to be increased in IVF preg- nancies compared to spontaneous gestations, leading to a falsely ele- vated trisomy screening risk. The aim of this preliminary study was to find out whether, in the first-trime- ster screening, the markers similarly differed between IVF and spontane- ous pregnancies which would call for the establishment of separate normal medians for IVF patients. We compared 24 pregnancies ob- tained after ovarian stimulation and IVF with six women after thawed embryo transfer (unstimulated cycle) and 63 gestation- and maternal-age matched spontaneously pregnant controls. A single serum was ob- tained between 6 and 16 weeks of gestation and various placental protein levels determined by im- munometric assays. Serum levels of pregnancy-associated plasma protein A (PAPP-A), which is the major marker in the first-trimes- ter screening test, were reduced in IVF pregnancies: after 9 weeks of gestation, multiples of median (MoMs) ranged between 0.23 and 3.58 (logarithmic mean 0.743). For the frozen/thawed transfers, this value was 1.08. In the 9-12 week group containing 6 cases of IVF, three thawed transfers and 25 con- trols, PAPP-A was significantly redu- ced in the stimulated compared to the nonstimulated cycles. In the late first and early second trimester the difference was not significant in our small group but the trend persisted. Pregnancies after IVF will thus show an increased incidence of false positive results in fetal trisomy-21 screening, and special medians should be established for these pati- ents.

Strategie für eine Informationsgesellschaft in der Schweiz : eine zehnjährige Politik im Lichte empirischer Analyse

Im Februar 1998 schuf der Bundesrat mit der Strategie für eine Informationsgesellschaft in der Schweiz die Grundlage für eine heute noch aktuelle Politik. Diese wird in der vorliegenden Arbeit einer empirischen, quellenbasierten Analyse unterzogen. Hierbei wird gefragt, welches Bild einer realen, möglichen oder künftigen Informationsgesellschaft den untersuchten Texten zugrundeliegt und wie es sich während der Umsetzung der Strategie im Laufe von zehn Jahren verändert hat. Als Vergleichsmassstab dient das entsprechende Programm der UNO, das auf dem World Summit on the Information Society 2003 und 2005 formuliert wurde. In einer Detailanalyse wird darüber hinaus beschrieben, wie sich die Strategie für eine Informationsgesellschaft auf die Arbeit in Schweizer Archiven und Bibliotheken ausgewirkt hat. Insgesamt entsteht das Bild einer in Zielen und Inhalten erstaunlich variablen und wirtschaftsorientierten Politik. En adoptant la Stratégie pour une société de l'information en Suisse, en février 1998, le Conseil fédéral a jeté les bases d'une politique qui a gardé toute son actualité. Dans le présent travail, celle-ci fait l'objet d'une analyse empirique, basée sur les sources. On y cherche à savoir sur quelle vision d'une société d'information réelle, possible ou future reposent les textes étudiés, et de quelle manière cette image s'est modifiée sur une période de dix ans de mise en oeuvre de la stratégie. Le programme de même type de l'ONU, élaboré en 2003 et 2005 lors du World Summit on the Information Society, fait office de base de comparaison. Une analyse détaillée décrit par ailleurs quels effets la Stratégie pour une société de l'information a eus sur le travail des archives et bibliothèques suisses. Il en résulte un tableau d'ensemble d'une politique étonnamment diversifiée et proche de la réalité économique, tant sur le plan des objectifs que du contenu.

Drug monographs on drugs which are frequently analysed in the context of Therapeutic Drug Monitoring = Arzneimittel-Monographien für Medikamente, die regelmässig im Rahmen des Therapeutic Drug Monitorings analysiert werden

In addition to the monographs which were published last year by the working group "Drug Monitoring" of the Swiss Society of Clinical Chemistry (SSCC) [1], new monographs have been written. The aim of these monographs is to give an overview of the most important information necessary for ordering a drug analysis or interpreting the results. Therefore, the targeted readers comprise laboratory health professionals and all receivers of laboratory reports. There is information provided on the indication for therapeutic drug monitoring, protein binding, metabolic pathways and enzymes involved, elimination half-life and elimination routes, and on therapeutic or toxic concentrations. Preanalytical considerations are of particular importance for therapeutic drug monitoring. Therefore, information is provided regarding a reasonable timing for the determination of drug concentrations as well as steady-state concentrations after changing the dose. Furthermore, the stability of the drug and its metabolite(s) after blood sampling is described. For readers with a specific interest in drug analysis, references to important publications are given. The number of monographs will be continuously enlarged. The updated files are presented on the homepage of the SSCC (www.sscc.ch).

Konsensusempfehlungen zur Beurteilung der medizinischen Mindestanforderungen für Fahreignung bei kognitiver Beeinträchtigung [Consensus recommendations for the assessment of fitness to drive in cognitively impaired patients].

Memory Clinics provide evidence based diagnosis and treatment of dementia. Whenever a diagnosis of dementia is made, it is important to inform the patients about the possible impact of dementia on driving. Patients and their next of kin require competent advice whenever this difficult question is addressed and the mobility desire and the risks related to driving need to be carefully weight up. The time of diagnosis does not necessarily equate to the time when a person with dementia becomes an unsafe driver. The cause and severity of dementia, comorbidities and the current medication need to be carefully taken into account for this decision. On behalf of the association of the Swiss Memory Clinics, a group of experts has developed recommendations to assess fitness to drive in cognitively impaired older adults.